Spine

Kelly Shelton Appointed President of Osseus

DALLAS, TX, November 14, 2022 /OrthoSpineNews/ – Osseus Fusion Systems, LLC (d.b.a. Osseus), a pioneering spinal fusion solutions company, announces that Kelly Shelton will join the company as President effective immediately.

As the President, Mr. Shelton’s initial focus will be to oversee revenue-generating activities at Osseus including organic sales and channel strategies, group purchasing organization (“GPO”) partnerships, customer retention, marketing, development opportunities, as well as expanding the Osseus product portfolio.

On his appointment, Mr. Shelton commented, “My career has always been driven by a passion for clinical outcomes, managing high performing business development teams, and building and maintaining surgeon and hospital relationships. I am excited to be joining an organization committed to delivering exceptional patient care and surgeon support. Our organization is empowered to grow, compete, and win in a large, expanding, and highly fragmented Orthopedic and Neurosurgery market.”

“Kelly has more than 25 years of experience delivering impressive results as a competitive sales and operational leader in the healthcare industry,” said Rob Pace, Osseus CEO. “His primary objectives will include scaling our platform through continued organic growth, driving our offering for channel sales partnerships, and delivering excellent results from the team he is mentoring. Kelly’s skills are a great fit for our company and the Osseus brand as we enter our next phase of growth and development.”

Prior to joining Osseus, Mr. Shelton served as Vice President of Zimmer Biomet Spine where he led a team that generated more than $500 million in global annual sales. Before that, Mr. Shelton was Area Vice President at Stryker Spine where he grew strategic accounts and negotiated and closed numerous GPO contracts. Mr. Shelton earned a Bachelor of Science in Organizational Management from Colorado State University and a Master of Business Administration from the University of Denver.

About Osseus:
Osseus is a privately held, organically funded medical device firm focused on offering minimally invasive solutions to the growing US spine market. Founded in 2014 and grown in Dallas, Texas, Osseus pushes the evolution of spinal fusion products with its teams of forward-thinking surgeons, bright-minded engineers, and visionary product managers. The Osseus product line includes 11 FDA approved spinal fusion and fixation systems including: the Pisces-SA Standalone ALIF Interbody System, Black Diamond Open and Minimally Invasive Pedicle Screw Systems, Black Diamond POCT Posterior Cervical Screw System, White Pearl Anterior Cervical Plate, Gemini-C Cervical Interbody, Aries-TS, -TC, -L, and – A Lumbar Interbody Systems and Blue Topaz Sacroiliac Screw System.

For more information, please email info@osseus.com.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button